Quantifying the utility of a multidisciplinary neuro-oncology tumor board

Adham M Khalafallah1, Adrian E Jimenez1, Carlos G Romo2,3

  • 11Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore.

Journal of Neurosurgery
|September 18, 2020
PubMed
Abstract

Insights

Multidisciplinary tumor boards (MDTBs) significantly altered diagnoses and treatment plans for nervous system tumors. These collaborative discussions also reduced patient referral times, improving care efficiency.

Area of Science:

  • Neuro-oncology
  • Medical oncology
  • Clinical research

Background:

  • Limited research exists on the effectiveness of multidisciplinary tumor boards (MDTBs) for nervous system tumors.
  • MDTBs involve a team of specialists to discuss complex patient cases.

Purpose of the Study:

  • To quantify the utility of MDTBs in improving diagnostic interpretations and treatment strategies for patients with nervous system tumors.
  • To assess the impact of MDTBs on patient management and referral times.

Main Methods:

  • A prospective study was conducted across 4 hospitals from July to November 2019.
  • 176 patient cases discussed at MDTBs were analyzed for demographic data, diagnoses, and treatment plans.
  • Data on image interpretation, management changes, and clinical trial eligibility were recorded.

Main Results:

  • MDTBs resulted in a 21.6% change in image interpretation and a 58.2% change in patient management.
  • The most common diagnosis was glioblastoma (32.4%).
  • Patients discussed in MDTBs experienced significantly shorter referral times (p = 0.024).

Conclusions:

  • MDTB discussions led to substantial diagnostic and treatment plan modifications for nervous system tumors.
  • The findings underscore the clinical value of multidisciplinary care in neuro-oncology.
  • Shortened referral times indicate improved efficiency in patient care pathways.

Related Concept Videos